GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of AcrySof IQ VivityTM, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Author: Business Wire
Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer’s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2021, to discuss top-line symptom, redness, and Schirmer’s test results from the run-in …
Noveome Biotherapeutics, Inc. Publishes Preclinical Results Demonstrating Neuroprotective Properties of ST266 Require Full Complement of Proteins
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics has published preclinical results evaluating the neuroprotective properties of its ST266 therapeutic in the journal PLOS ONE.
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Markets, 2020-2024 – Increasing Medical Tourism for LASIK Surgery Driving Market Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The laser-assisted in-situ keratomileusis (LASIK) surgery market is poised to grow …
Keratoconus Epidemiology Forecast Report 2017-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconus – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Keratoconus (KC) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, hist…
RMEI Medical Education, LLC – An International Leader in Patient-Centric, Practice-Based Continuing Education – Earns Interprofessional Joint Accreditation for the Healthcare Team
VOORHEES, N.J.–(BUSINESS WIRE)– #ACCME–RMEI Medical Education, LLC (RMEI) announced today that it has been granted Joint Accreditation™ for Interprofessional Continuing Education.
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio granted non-statutory stock options to purchase an aggregate of 28,000 shares of common stock to two newly hired, non-executive employees.
Kopin Corporation Ships First Production Order of 720p Color OLED Microdisplays
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of high-resolution microdisplays and display subassemblies for defense, enterprise, industrial, consumer and medical products, announced today it h…
Samsara Vision Appoints Three New Members to the Board of Directors
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision is pleased to announce the appointment of three new members to its Board of Directors.
Midwest Vision Partners Announces Partnership With Parschauer Eye Center
CHICAGO & SANDUSKY, Ohio–(BUSINESS WIRE)– #eyecare–Midwest Vision Partners announces its 8th partnership to date with Parschauer Eye Center, expanding its network to 95+ physicians and 44 locations.
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will participa…
The Donate Life Community, Along With NJ Sharing Network and 14 Other Sponsors From Around the Nation, Invite Audiences to Watch the 2021 Rose Parade TV Special on New Year’s Day
LOS ANGELES–(BUSINESS WIRE)– #2021RoseParade–The Donate Life Community, NJ Sharing Network and 14 other sponsors invite audiences to watch the 2021 Rose Parade TV special on New Year’s Day.
Global Ocular Drug Delivery Market Overview, Delivery Technologies and Partnering Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition” report has been added to ResearchAndMarkets.com’s offering. Millions of people worldwide are affected by various eye d…
Global Contact Lens Market Insights & Forecast 2020-2024 with COVID-19 Impact Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market is forecasted to reach US$9.92 b…
VisionQuest Biomedical Inc. Gains FDA 510(k) Clearance for the Image Quality Analyzer Software
ALBUQUERQUE, N.M.–(BUSINESS WIRE)– #510k–VisionQuest Biomedical Inc. (VisionQuest) announced today that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the Image Quality Analyzer (IQA) so…
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
NEW YORK–(BUSINESS WIRE)– #FDA–Eyenovia has submitted an NDA to the FDA for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent delivered by the Optejet dispenser.
Ocular TherapeutixTM Announces Exercise of Underwriters’ Option to Purchase Additional Shares
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market Research 2020-2024 | Post-Pandemic Industry Planning Structure by Technavio
LONDON–(BUSINESS WIRE)– #GlobalLaserAssistedInSituKeratomileusisLASIKSurgeryMarket–The Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market will grow by $ 375.04 mn during 2020-2024
Eyewear Market to Accelerate at a CAGR of Almost 8% | Research Report by Technavio
LONDON–(BUSINESS WIRE)– #GlobalEyewearMarket–The Eyewear Market will grow by USD 57.69 bn during 2020-2024
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …